Bönnemann Carsten G
Neuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch, National Institute of Neurological Disorders and Stroke/NIH, Bethesda, MD 20892-3705, USA.
Handb Clin Neurol. 2011;101:81-96. doi: 10.1016/B978-0-08-045031-5.00005-0.
Mutations in the genes COL6A1, COL6A2, and COL6A3, coding for three α chains of collagen type VI, underlie a spectrum of myopathies, ranging from the severe congenital muscular dystrophy-type Ullrich (UCMD) to the milder Bethlem myopathy (BM), with disease manifestations of intermediate severity in between. UCMD is characterized by early-onset weakness, associated with pronounced distal joint hyperlaxity and the early onset or early progression of more proximal contractures. In the most severe cases ambulation is not achieved, or it may be achieved only for a limited period of time. BM may be of early or later onset, but is milder in its manifestations, typically allowing for ambulation well into adulthood, whereas typical joint contractures are frequently prominent. A genetic spectrum is emerging, with BM being caused mostly by dominantly acting mutations, although rarely recessive inheritance of BM is also possible, whereas both dominantly as well as recessively acting mutations underlie UCMD.
编码胶原蛋白VI型的三条α链的COL6A1、COL6A2和COL6A3基因发生突变,是一系列肌病的病因,这些肌病范围从严重的先天性肌营养不良型乌尔里希病(UCMD)到较轻的贝思伦肌病(BM),中间还存在症状严重程度介于两者之间的情况。UCMD的特征是起病早,伴有明显的远端关节过度松弛以及更靠近端挛缩的早发或早期进展。在最严重的病例中,无法行走,或者仅在有限的时间段内能够行走。BM可能早发或晚发,但其症状较轻,通常在成年期仍能行走,而典型的关节挛缩则较为常见。一种遗传谱正在显现,BM主要由显性作用的突变引起,不过BM也很少可能是隐性遗传,而UCMD则由显性和隐性作用的突变共同引起。